Al­ny­lam plans to ap­peal Covid-19 vac­cine patent rul­ing in case against Mod­er­na

Al­ny­lam agreed to a fi­nal judg­ment that Mod­er­na did not in­fringe on two of Al­ny­lam’s patents, though the com­pa­ny said Fri­day it plans to ap­peal the rul­ing.

Judge Colm Con­nol­ly of the US Dis­trict Court for the Dis­trict of Delaware is­sued an or­der last week against Al­ny­lam on cer­tain patent claims. The com­pa­ny sued Mod­er­na in 2022, al­leg­ing in two suits that the com­pa­ny’s Covid-19 vac­cine in­fringed on Al­ny­lam patents. It al­so sued Pfiz­er, mak­ing sim­i­lar al­le­ga­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER